4-Hydroxytamoxifen suppresses the malignant progression of lung adenocarcinoma by inhibiting MAPK signaling pathway
Scientific Reports, Published online: 13 August 2026; doi:10.1038/s41598-026-61557-9 4-Hydroxytamoxifen suppresses the malignant progression of lung adenocarcinoma by inhibiting MAPK signaling pathway
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.